← Open Payments lookup

ARCEL GULAPA: Open Payments

NPI 1902203359 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,143 in 41 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $1,143

Food & beverage: $1,143
CompanyPaymentsAmount
Novo Nordisk Inc12$351
AstraZeneca Pharmaceuticals LP4$272
Bayer Healthcare Pharmaceuticals Inc.5$110
Lilly USA, LLC5$102
Amgen Inc.4$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$63
GlaxoSmithKline, LLC.2$54
Sumitomo Pharma America, Inc.1$27
Corcept Therapeutics1$22
PFIZER INC.1$20

Products named: Wegovy, AIRSUPRA, Ozempic, BREZTRI, Kerendia, MOUNJARO, RELISTOR, REPATHA.

Industry payments across CA — which companies pay providers there.